Startups channel feed – Endpoints News

Startups channel feed

Exclusive: Covid and epidemic threat biotech Aerium Therapeutics closes after emergence of variants

9 months ago

Arie Belldegrun and team unveil $600M life sciences credit firm amid struggling biotech market

9 months ago

Exclusive: TCG, DCVC and Lux back new autoimmune biotech from Kallyope co-founder

9 months ago

A new Apple Tree Partners biotech launches with $55M to make ‘pan-variant’ antivirals

9 months ago

Third Rock and Arie Belldegrun’s firm come together for CD20/CD3 bispecific out of China

9 months ago

Florida CNS gene therapy biotech shuts down

9 months ago

Exclusive: Devoted Health raises $112M, plots insurance markets expansion

9 months ago

Apogee and Spyre founder launches another autoimmune biotech, and it's got $80M to start

9 months ago

PARP biotech backed by more than five pharmas closes after nine years

9 months ago

Exclusive: Ultragenyx secures first funds for Alzheimer's gene therapy spinout

9 months ago

With $144M Series B, Outpace Bio beats funding goal for solid tumor cell therapies

9 months ago

As Amgen pursues GIP antagonism, a Novo Holdings-backed biotech does the same, boosting its Series A

9 months ago

RNA editing startup AIRNA raises $60M for clinical trial in rare liver disease

9 months ago

Behind Boehringer’s up to $1.3B Nerio deal is a budding cancer pipeline and aim to ‘leapfrog AbbVie’

9 months ago

Exclusive: Startup aims to tackle ‘undruggable’ neuro targets with tech from Kevan Shokat's UCSF lab

9 months ago

Boehringer Ingelheim buys oncology biotech for up to $1.3B

9 months ago

In a tough market, private biotechs pursue IPOs and buyouts at the same time

9 months ago

Neurology startup from OrbiMed collab nabs $65M in Series A

9 months ago

At Third Arc Bio, former J&J leaders raise $165M to test oncology, autoimmune biologics

9 months ago

Flagship launches AI-powered biologics biotech with $50M backing

9 months ago

Health tech startup Commure bets on AI for medical notes in $139M deal

9 months ago

Where Oak HC/FT investor Nancy Brown is placing her bets on AI in health tech

9 months ago

OrbiMed forms biotech with assets from China-based Keymed, enlists former Biohaven exec as CEO

9 months ago

Artiva's IPO raises $167M to fund company's autoimmune and cancer cell therapies

9 months ago

First page Previous page 11 12 131415 16 17 Next page Last page